研究成果


第 1 到 28 筆結果，共 28 筆。

公開日期標題作者來源出版物scopusWOS全文
12023Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBANG-BIN CHEN ; PO-CHIN LIANG ; TIFFANY TING-FANG SHIH ; TSUNG-HAO LIU ; YING-CHUN SHEN ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO European radiology1713
22023Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer MacrophagesDu, Li; Ji, Yichun; Xin, Bing; Zhang, Jiemeng; LI-CHUN LU ; Glass, Christopher K; Feng, Gen-ShengCellular and molecular gastroenterology and hepatology32
32022Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatmentChen, Ching-Tso; Feng, Yin-Hsun; Yen, Chia-Jui; Chen, San-Chi; Lin, Yun-Tzu; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG ; YU-YUN SHAO Hepatology international1414
42022Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceWang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO Annals of hematology109
52022ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology AnalysisLI-CHUN LU ; Deantonio, Cecilia; Palu, Cintia C; Lee, Yi-Hsuan; Mitchell, Laura S; Cowan, Marianne; Corser, Matthew; Sherry, Lorcan; ANN-LII CHENG ; Quaratino, Sonia; YU-YUN SHAO ; Sainson, Richard C A; CHIH-HUNG HSU Oncology (Switzerland)00
62021Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor SitesGUO, JHE-CYUAN ; Lin, Chen Yuan; CHIA-CHI LIN ; TA-CHEN HUANG ; Lien, Ming Yu; LI-CHUN LU ; HUNG-YANG KUO ; CHIH-HUNG HSU ONCOLOGY (United States)11
72021Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistanceWang, Yulei; LI-CHUN LU ; Guan, Yinghui; MING-CHIH HO ; Lu, Shan; Spahn, Jessica; CHIH-HUNG HSU Experimental hematology & oncology1515
82021Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinomaSHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH Oncoimmunology34
92021Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapyYING-CHUN SHEN ; Yeh C.-P.; YUNG-MING JENG ; CHIUN HSU ; CHIH-HUNG HSU ; ZHONG-ZHE LIN ; YU-YUN SHAO ; LI-CHUN LU ; TSUNG-HAO LIU ; CHIEN-HUNG CHEN ; ANN-LII CHENG Cancers22
102021Solving the deficit of cancer pain management skills by education programsYU-YUN SHAO ; WEN-YING LIN ; CHIH-PENG LIN ; LI-CHUN LU ; CHIH-HUNG HSU Supportive Care in Cancer22
112019Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTSUNG-HAO LIU ; YU-YUN SHAO ; LI-CHUN LU ; Ying-Chun Shen ; CHIUN HSU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; ANN-LII CHENG Expert Review of Gastroenterology and Hepatology57
122019Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib TreatmentLI-CHUN LU ; Lee, Yi Hsuan; Chang, Chun Jung; CHIA-TUNG SHUN ; Fang, Chih Yeu; YU-YUN SHAO ; TSUNG-HAO LIU ; ANN-LII CHENG ; CHIH-HUNG HSU Liver Cancer4541
132019Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular CarcinomaLI-CHUN LU ; CHIUN HSU ; YU-YUN SHAO ; Chao Y.; Yen C.-J.; I-LUN SHIH ; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen ; JHE-CYUAN GUO ; TSUNG-HAO LIU ; CHIH-HUNG HSU ; ANN-LII CHENG Liver Cancer4644
142019Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYU-YUN SHAO ; TSUNG-HAO LIU ; CHIUN HSU ; LI-CHUN LU ; YING-CHUN SHEN ; ZHONG-ZHE LIN ; ANN-LII CHENG ; CHIH-HUNG HSU Liver International5658
152018Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinomaChang C.-J.; YAO-HSU YANG ; Chiu C.-J.; LI-CHUN LU ; Liao C.-C.; Liang C.-W.; CHIH-HUNG HSU ; ANN-LII CHENG International Journal of Cancer4437
162017Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population studyLI-CHUN LU ; PEI-JER CHEN ; Yeh Y.-C.; CHIH-HUNG HSU ; Chen H.-M.; Lai M.-S.; YU-YUN SHAO ; ANN-LII CHENG Anticancer Research1516
172016Tumor-associated neutrophils: An emerging player in the immune microenvironment of hepatocellular carcinomaLI-CHUN LU ; CHIH-HUNG HSU Translational Cancer Research22
182016Tumor heterogeneity in hepatocellular carcinoma: Facing the challengesLI-CHUN LU ; CHIH-HUNG HSU ; CHIUN HSU ; ANN-LII CHENG Liver Cancer9598
192016Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinomaLin H.-H.; Feng W.-C.; LI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG Cancer letters3639
202015Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trialsYU-YUN SHAO ; Shau, W.-Y.; Chan, S.-Y.; LI-CHUN LU ; CHIH-HUNG HSU ; ANN-LII CHENG Oncology (Switzerland)2929
212014β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinomaLI-CHUN LU ; YU-YUN SHAO ; Lee Y.-H.; MIN-SHU HSIEH ; Hsiao C.-H.; Lin H.-H.; HSIANG-FONG KAO ; Ma Y.-Y.; Yen F.-C.; ANN-LII CHENG ; CHIH-HUNG HSU Oncology (Switzerland)2524
222014Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapyLI-CHUN LU ; YU-YUN SHAO ; Chan S.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG Anticancer Research1210
232014Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapyYU-YUN SHAO ; CHIH-HORNG WU ; LI-CHUN LU ; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; CHIH-HUNG HSU ; ANN-LII CHENG Journal of Hepatology4548
242014Recent advances in the prevention of hepatocellular carcinoma recurrenceLI-CHUN LU ; ANN-LII CHENG ; Poon R.T.P.Seminars in Liver Disease5044
252013Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinomaLI-CHUN LU ; YU-YUN SHAO ; Kuo R.N.C.; ZHONG-ZHE LIN ; Yeh Y.-C.; Shau W.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG ; Lai M.-S.Cancer1111
262012Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancerLI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; CHIUN HSU ; WEN-FANG CHENG ; YU-LIN LIN ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research0
272012Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systemsYU-YUN SHAO ; LI-CHUN LU ; ZHONG-ZHE LIN ; CHIUN HSU ; Ying-Chun Shen ; CHIH-HUNG HSU ; ANN-LII CHENG British Journal of Cancer2626
282011Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapyYU-YUN SHAO ; LI-CHUN LU ; ANN-LII CHENG ; CHIH-HUNG HSU Oncologist3428